Bifidobacterium is an anaerobic bacterium that can grow well and sufficiently in the low-oxygen state of the tumor microenvironment, and through STING signaling and interferon type I, it can improve anti-CD47 immunotherapy, which does not allow the tumor cells to escape and causes them to be swallowed by macrophages [3]. The gene discussed is CD47; the disease is neoplasm.